Johnson & Johnson Innovation JLABS @ TMC, Houston.
With a lead investment from the UK-based Wellcome Trust, a premier international medical foundation, CorInnova is developing a non-blood contacting cardiac assist device. CorInnova's device is a transformative biventricular device to treat acute heart failure. The technology will create a new paradigm for treatment. The device is designed to eliminate 40% of the adverse events associated with existing cardiac assist technologies, and may expand eligible patients by 3 to 4 times. The device may reverse the progression of HF, a blockbuster application. The device deploys minimally invasively into the pericardial sac in under 30 seconds, and has shown the ability to increase cardiac output by up to 50%. Addressable markets are up to $8 billion.
With a lead investment from the UK-based Wellcome Trust, a premier international medical foundation, CorInnova is developing a non-blood contacting cardiac assist device. CorInnova's device is a transformative biventricular device to treat acute heart failure. The technology will create a new paradigm for treatment. The device is designed to eliminate 40% of the adverse events associated with existing cardiac assist technologies, and may expand eligible patients by 3 to 4 times. The device may reverse the progression of HF, a blockbuster application. The device deploys minimally invasively into the pericardial sac in under 30 seconds, and has shown the ability to increase cardiac output by up to 50%. Addressable markets are up to $8 billion.
Location: United States, Texas, Houston
Employees: 11-50
Total raised: $6.1M
Investors 7
| Date | Name | Website |
| - | SWPDC | swpdc.org/ |
| - | TMC Ventur... | tmcventure... |
| - | Cowtown An... | cowtownang... |
| - | Frontera T... | fronterate... |
| 13.04.2023 | Keiretsu F... | keiretsufo... |
| - | K2X | k2x.capita... |
| - | Springtime... | springtime... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 30.10.2017 | - | $6.1M | - |
Mentions in press and media 6
| Date | Title | Description |
| 30.12.2024 | 2024 Rising Stars Shine at iC³ Summit: Celebrating Progress and Setting the Stage for 2025 | DALLAS, Dec. 30, 2024 (GLOBE NEWSWIRE) -- The 2024 Rising Stars of the life sciences and healthcare innovation sector took center stage at the iC³ Life Science Summit this year, marking another milestone in recognizing groundbreaking achiev... |
| 27.02.2020 | 11 startups pitch top Houston angel investors at biannual summit | The Houston Angel Network checked in with their investors and portfolio companies at their biannual Houston Angel Summit that gathered HAN members, local investors, and startup founders for a day full of educational opportunities, pitches, ... |
| 07.11.2019 | Rice Alliance names most promising life science companies at annual forum | Houston hosted an annual meeting of the minds that included thoughtful discussions, presentations, panels, and startup pitches within the life science industry. The Texas Life Science Forum, organized and hosted by the Rice Alliance and Bio... |
| 29.04.2019 | Pitch Perfect Winner Spotlight: CorInnova wants to change the way we treat failing hearts | Additionally, the high eligibility requirements for the procedure used to implant these pumps mean that many individuals suffering from heart failure are shut out from receiving these technologies. Houston-based CorInnova is hoping its robo... |
| 30.10.2017 | Corinnova Nets $6.1M from Wellcome for Heart Failure Medical Device | Share Share on Facebook Share on Twitter LinkedIn Email Reprints Houston—More than 12 million people in the United States and European Union have congestive heart failure, but there are only about 4,500 hearts available each year for transp... |
| - | Pitch Perfect Winner Spotlight: CorInnova wants to change the way we treat failing hearts | From left: MedCity News Editor in Chief Arundhati Parmar, CorInnova CEO William Altman, and MHIN President Dennis Depenbusch Heart failure patients have few options for prolonging life and improving cardiac function. Outside of a heart tran... |